U.S., Nov. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07223138) titled 'A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis' on Oct. 20.
Brief Summary: This is a study to demonstrate the long-term safety, tolerability and clinical efficacy of sonelokimab in the treatment of patients with psoriatic arthritis who completed a parental study (M1095-PSA-301 or M1095-PSA-302)
Study Start Date: Oct. 20
Study Type: INTERVENTIONAL
Condition:
Arthritis, Psoriatic
Intervention:
DRUG: Sonelokimab
Open-label
Recruitment Status: NOT_YET_RECRUITING
Sponsor: MoonLake Immunotherapeutics AG
Published by HT Digital Content Servi...